Skip to main content


Fig. 5 | BMC Cancer

Fig. 5

From: Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation

Fig. 5

Expected Value of Perfect Information. The EVPI can be interpreted as the maximum amount the decision maker would be willing to spend to obtain perfect information. The Expected Value of Perfect Information (EVPI) amounted to almost €3 M, indicating the upper boundary for investing research funds in further clinical trials to obtain perfect information on the cost-effectiveness of TIL versus ipilimumab

Back to article page